Bernard and Shirlee Brown Glaucoma Research Laboratory, Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York, New York.
Department of Psychology, Columbia University, New York, New York.
JAMA Ophthalmol. 2021 Jan 1;139(1):27-32. doi: 10.1001/jamaophthalmol.2020.4749.
Facial recognition is a critical activity of daily living that relies on macular function. Glaucomatous macular damage may result in impaired facial recognition that may negatively affect patient quality of life.
To evaluate the association of patterns of glaucomatous macular damage with contrast sensitivity and facial recognition among patients with glaucoma.
DESIGN, SETTING, AND PARTICIPANTS: In this prospective cohort study at a single tertiary care center, 144 eyes of 72 consecutive patients with glaucoma with good visual acuity (20/40 or better in each eye) were studied. Data were collected from March to April 2019.
Eyes with macular damage were categorized as having focal, diffuse, or mixed (focal and diffuse) damage based on optic disc and macular spectral-domain optical coherence tomography and 10-2 visual field (VF) damage. Only eyes with focal or diffuse damage were included. Higher-acuity and lower-acuity eyes were determined by 10-2 VF mean deviation (MD). Facial disability was defined as facial recognition scores at the 2% level of normal participants.
(1) Monocular contrast threshold as measured by the Freiburg Visual Acuity and Contrast Test and (2) binocular facial recognition as measured by the Cambridge Face Memory Test.
Of the 72 included patients, 49 (68%) were White and 41 (57%) were female, and the mean (SD) age was 67.0 (11.6) years. Eyes with diffuse damage had greater contrast impairment compared with eyes with focal damage (β = -0.5; 95% CI, -0.6 to -0.4; P < .001) after adjusting for 10-2 VF MD, 24-2 VF MD, age, presence of an early cataract, and number of drops. Similarly, Cambridge Face Memory Test scores were significantly lower in patients with diffuse rather than focal macular damage, regardless of eye (better-seeing eye: β = 10.0; 95% CI, 2.0 to 18.2; P = .001; worse-seeing eye: β = 5.5; 95% CI, 0.8 to 10.0; P = .23). Relative risk of facial disability was greater for patients with diffuse but not focal macular damage in the better-seeing eye (relative risk, 86.2; 95% CI, 2.7 to 2783.3; P = .01).
In this cohort study, diffuse rather than focal glaucomatous macular damage was associated with diminished facial recognition and contrast sensitivity. Evaluation of macular optical coherence tomography and 10-2 VF and resultant detection of diffuse macular damage may help minimize glaucoma-related visual disability.
面部识别是日常生活中的一项重要活动,它依赖于黄斑功能。青光眼性黄斑损伤可能导致面部识别受损,从而对患者的生活质量产生负面影响。
评估青光眼患者黄斑损伤模式与对比敏感度和面部识别之间的关联。
设计、地点和参与者:在这项于一家三级保健中心进行的前瞻性队列研究中,研究了 72 例连续青光眼患者的 144 只眼,这些患者视力良好(每只眼的视力均为 20/40 或更好)。数据于 2019 年 3 月至 4 月收集。
根据视盘和黄斑谱域光相干断层扫描以及 10-2 视野(VF)损伤,将黄斑损伤的眼睛分为局灶性、弥漫性或混合性(局灶性和弥漫性)损伤。仅包括具有局灶性或弥漫性损伤的眼睛。高敏度和低敏度眼由 10-2 VF 平均偏差(MD)确定。面部残疾定义为面部识别分数在正常参与者的 2%水平。
(1)弗赖堡视力和对比度测试测量的单眼对比度阈值;(2)剑桥面部记忆测试测量的双眼面部识别。
在纳入的 72 例患者中,49 例(68%)为白人,41 例(57%)为女性,平均(SD)年龄为 67.0(11.6)岁。与局灶性损伤相比,弥漫性损伤的眼睛具有更大的对比度损伤(β=−0.5;95%CI,−0.6 至−0.4;P<0.001),调整了 10-2 VF MD、24-2 VF MD、年龄、早期白内障的存在和滴数。同样,无论眼睛(视力较好的眼睛:β=10.0;95%CI,2.0 至 18.2;P=0.001;视力较差的眼睛:β=5.5;95%CI,0.8 至 10.0;P=0.23),患有弥漫性黄斑损伤的患者的剑桥面部记忆测试分数明显低于局灶性黄斑损伤患者。在视力较好的眼睛中,患有弥漫性黄斑损伤的患者面部残疾的相对风险大于局灶性黄斑损伤(相对风险,86.2;95%CI,2.7 至 2783.3;P=0.01)。
在这项队列研究中,与局灶性相比,弥漫性青光眼性黄斑损伤与面部识别和对比敏感度下降有关。评估黄斑光相干断层扫描和 10-2 VF 并检测到弥漫性黄斑损伤可能有助于最大限度地减少与青光眼相关的视觉障碍。